Larry Michael Mertz - Mar 2, 2023 Form 4 Insider Report for Accelerate Diagnostics, Inc (AXDX)

Role
Chief Technology Officer
Signature
/s/ Steven Reichling, attorney-in-fact
Stock symbol
AXDX
Transactions as of
Mar 2, 2023
Transactions value $
-$16,366
Form type
4
Date filed
3/6/2023, 06:41 PM
Previous filing
Feb 15, 2023
Next filing
May 24, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXDX Common Stock Options Exercise $0 +116K +26.84% $0.00 550K Mar 2, 2023 Direct F1
transaction AXDX Common Stock Sale -$16.4K -33.4K -6.08% $0.49 516K Mar 2, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXDX Employee Restricted Stock Units Options Exercise $0 -116K -100% $0.00* 0 Mar 2, 2023 Common Stock 116K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On February 13, 2023, the reporting person was granted a total of 116,329 restricted stock units, which fully vested on March 2, 2023.
F2 The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.